Therefore, further studies investigating the detailed molecular mechanism that regulates IL-19 and IL-20, and the crosstalk between these two cytokines in these three cell types will be clinically important, especially the question of whether there is an additive or synergistic effect between IL-19 and IL-20 in the course of AKI. The gene discussed is IL20; the disease is acute kidney injury.